{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:39:59Z","timestamp":1792190399229,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangxi Provincial Natural Science Foundation Key Project","award":["20232ACB206032"],"award-info":[{"award-number":["20232ACB206032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10495-023-01931-4","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T20:02:32Z","timestamp":1707768152000},"page":"799-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer"],"prefix":"10.1007","volume":"29","author":[{"given":"Zitao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"issue":"6","key":"1931_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1931_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00464-017-5640-8","volume":"32","author":"KY Hahn","year":"2018","unstructured":"Hahn KY, Park CH, Lee YK, Chung H, Park JC, Shin SK et al (2018) Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer. Surg Endosc 32(1):73\u201386. https:\/\/doi.org\/10.1007\/s00464-017-5640-8","journal-title":"Surg Endosc"},{"issue":"1","key":"1931_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-020-01042-y","volume":"24","author":"Japanese Gastric Cancer Association","year":"2021","unstructured":"Japanese Gastric Cancer Association (2021) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 24(1):1\u201321. https:\/\/doi.org\/10.1007\/s10120-020-01042-y","journal-title":"Gastric Cancer"},{"issue":"1","key":"1931_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","volume":"19","author":"L Wei","year":"2020","unstructured":"Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L et al (2020) Noncoding Rnas in gastric cancer: implications for drug resistance. Mol Cancer 19(1):62. https:\/\/doi.org\/10.1186\/s12943-020-01185-7","journal-title":"Mol Cancer"},{"issue":"4","key":"1931_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K et al (2020) Neoadjuvant immunotherapy leads to pathological responses in Mmr-proficient and Mmr-deficient early-stage colon cancers. Nat Med 26(4):566\u2013576. https:\/\/doi.org\/10.1038\/s41591-020-0805-8","journal-title":"Nat Med"},{"issue":"1","key":"1931_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41467-019-13880-1","volume":"11","author":"A Sheih","year":"2020","unstructured":"Sheih A, Voillet V, Hanafi LA, DeBerg HA, Yajima M, Hawkins R et al (2020) Clonal kinetics and single-cell transcriptional profiling of car-T cells in patients undergoing Cd19 car-T immunotherapy. Nat Commun 11(1):219. https:\/\/doi.org\/10.1038\/s41467-019-13880-1","journal-title":"Nat Commun"},{"issue":"4","key":"1931_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A (2017) Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168(4):707\u2013723. https:\/\/doi.org\/10.1016\/j.cell.2017.01.017","journal-title":"Cell"},{"issue":"5","key":"1931_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.trecan.2023.02.001","volume":"9","author":"K H\u00e4nggi","year":"2023","unstructured":"H\u00e4nggi K, Ruffell B (2023) Cell death, therapeutics, and the immune response in cancer. Trends Cancer 9(5):381\u2013396. https:\/\/doi.org\/10.1016\/j.trecan.2023.02.001","journal-title":"Trends Cancer"},{"issue":"1","key":"1931_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B et al (2022) Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol 15(1):174. https:\/\/doi.org\/10.1186\/s13045-022-01392-3","journal-title":"J Hematol Oncol"},{"issue":"5","key":"1931_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS (2021) Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol 18(5):1106\u20131121. https:\/\/doi.org\/10.1038\/s41423-020-00630-3","journal-title":"Cell Mol Immunol"},{"key":"1931_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fcimb.2020.00238","volume":"10","author":"P Samir","year":"2020","unstructured":"Samir P, Malireddi RKS, Kanneganti TD (2020) The panoptosome: a deadly protein complex driving pyroptosis, apoptosis, and necroptosis (Panoptosis). Front Cell Infect Microbiol 10:238. https:\/\/doi.org\/10.3389\/fcimb.2020.00238","journal-title":"Front Cell Infect Microbiol"},{"key":"1931_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fcimb.2020.00237","volume":"10","author":"S Christgen","year":"2020","unstructured":"Christgen S, Zheng M, Kesavardhana S, Karki R, Malireddi RKS, Banoth B et al (2020) Identification of the panoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (Panoptosis). Front Cell Infect Microbiol 10:237. https:\/\/doi.org\/10.3389\/fcimb.2020.00237","journal-title":"Front Cell Infect Microbiol"},{"key":"1931_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mib.2020.07.012","volume":"59","author":"DE Place","year":"2021","unstructured":"Place DE, Lee S, Kanneganti TD (2021) Panoptosis in microbial infection. Curr Opin Microbiol 59:42\u201349. https:\/\/doi.org\/10.1016\/j.mib.2020.07.012","journal-title":"Curr Opin Microbiol"},{"key":"1931_CR14","doi-asserted-by":"publisher","first-page":"108010","DOI":"10.1016\/j.pharmthera.2021.108010","volume":"232","author":"S Christgen","year":"2022","unstructured":"Christgen S, Tweedell RE, Kanneganti TD (2022) Programming inflammatory cell death for therapy. Pharmacol Therap 232:108010. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108010","journal-title":"Pharmacol Therap"},{"key":"1931_CR15","doi-asserted-by":"publisher","first-page":"115696","DOI":"10.1016\/j.biopha.2023.115696","volume":"168","author":"Y Xiong","year":"2023","unstructured":"Xiong Y (2023) The emerging role of panoptosis in cancer treatment. Biomed Pharmacother 168:115696. https:\/\/doi.org\/10.1016\/j.biopha.2023.115696","journal-title":"Biomed Pharmacother"},{"key":"1931_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.10.001","author":"A Pandeya","year":"2023","unstructured":"Pandeya A, Kanneganti TD (2023) Therapeutic potential of panoptosis: innate sensors, inflammasomes, and ripks in panoptosomes. Trends Mol Med. https:\/\/doi.org\/10.1016\/j.molmed.2023.10.001","journal-title":"Trends Mol Med"},{"key":"1931_CR17","doi-asserted-by":"publisher","first-page":"1120034","DOI":"10.3389\/fimmu.2023.1120034","volume":"14","author":"P Zhu","year":"2023","unstructured":"Zhu P, Ke ZR, Chen JX, Li SJ, Ma TL, Fan XL (2023) Advances in mechanism and regulation of panoptosis: prospects in disease treatment. Front Immunol 14:1120034. https:\/\/doi.org\/10.3389\/fimmu.2023.1120034","journal-title":"Front Immunol"},{"key":"1931_CR18","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","volume":"19","author":"Y Wang","year":"2021","unstructured":"Wang Y, Kanneganti TD (2021) From pyroptosis, apoptosis and necroptosis to panoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J 19:4641\u20134657. https:\/\/doi.org\/10.1016\/j.csbj.2021.07.038","journal-title":"Comput Struct Biotechnol J"},{"key":"1931_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091495","author":"JM Gullett","year":"2022","unstructured":"Gullett JM, Tweedell RE, Kanneganti TD (2022) It\u2019s all in the pan: crosstalk, plasticity, redundancies, switches, and interconnectedness encompassed by panoptosis underlying the totality of cell death-associated biological effects. Cells. https:\/\/doi.org\/10.3390\/cells11091495","journal-title":"Cells"},{"issue":"1","key":"1931_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41392-022-00889-0","volume":"7","author":"JF Lin","year":"2022","unstructured":"Lin JF, Hu PS, Wang YY, Tan YT, Yu K, Liao K et al (2022) Phosphorylated Nfs1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing panoptosis. Signal Transduct Target Therap 7(1):54. https:\/\/doi.org\/10.1038\/s41392-022-00889-0","journal-title":"Signal Transduct Target Therap"},{"key":"1931_CR21","doi-asserted-by":"publisher","first-page":"955355","DOI":"10.3389\/fgene.2022.955355","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Sun R, Chan S, Meng L, Xu Y, Zuo X et al (2022) Panoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer. Front Genet 13:955355. https:\/\/doi.org\/10.3389\/fgene.2022.955355","journal-title":"Front Genet"},{"key":"1931_CR22","doi-asserted-by":"publisher","first-page":"1164930","DOI":"10.3389\/fendo.2023.1164930","volume":"14","author":"P He","year":"2023","unstructured":"He P, Ma Y, Wu Y, Zhou Q, Du H (2023) Exploring panoptosis in breast cancer based on Scrna-Seq and Bulk-Seq. Front Endocrinol 14:1164930. https:\/\/doi.org\/10.3389\/fendo.2023.1164930","journal-title":"Front Endocrinol"},{"issue":"1","key":"1931_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12967-022-03641-y","volume":"20","author":"L Ren","year":"2022","unstructured":"Ren L, Yang Y, Li W, Zheng X, Liu J, Li S et al (2022) Cdk1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial-mesenchymal transition, G2\/M phase transition, and panoptosis. J Transl Med 20(1):444. https:\/\/doi.org\/10.1186\/s12967-022-03641-y","journal-title":"J Transl Med"},{"key":"1931_CR24","doi-asserted-by":"publisher","first-page":"888105","DOI":"10.3389\/fonc.2022.888105","volume":"12","author":"J Huang","year":"2022","unstructured":"Huang J, Jiang S, Liang L, He H, Liu Y, Cong L et al (2022) Analysis of panoptosis-related Lncrna-Mirna-Mrna network reveals Lncrna Snhg7 involved in chemo-resistance in colon adenocarcinoma. Front Oncol 12:888105. https:\/\/doi.org\/10.3389\/fonc.2022.888105","journal-title":"Front Oncol"},{"key":"1931_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136720","author":"R Karki","year":"2020","unstructured":"Karki R, Sharma BR, Lee E, Banoth B, Malireddi RKS, Samir P et al (2020) Interferon regulatory factor 1 regulates panoptosis to prevent colorectal cancer. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.136720","journal-title":"JCI Insight"},{"key":"1931_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-023-01135-2","author":"S Camilli","year":"2023","unstructured":"Camilli S, Lockey R, Kolliputi N (2023) Nuclear export inhibitors selinexor (Kpt-330) and Eltanexor (Kpt-8602) provide a novel therapy to reduce tumor growth by induction of panoptosis. Cell Biochem Biophys. https:\/\/doi.org\/10.1007\/s12013-023-01135-2","journal-title":"Cell Biochem Biophys"},{"issue":"6","key":"1931_CR27","doi-asserted-by":"publisher","first-page":"100551","DOI":"10.1016\/j.mcpro.2023.100551","volume":"22","author":"LX Liu","year":"2023","unstructured":"Liu LX, Heng JH, Deng DX, Zhao H, Zheng ZY, Liao LD et al (2023) Sulconazole induces panoptosis by triggering oxidative stress and inhibiting glycolysis to increase radiosensitivity in esophageal cancer. Mol Cell Proteom MCP 22(6):100551. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100551","journal-title":"Mol Cell Proteom MCP"},{"issue":"1","key":"1931_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13148-020-00832-6","volume":"12","author":"Y Ge","year":"2020","unstructured":"Ge Y, Ma G, Liu H, Lin Y, Zhang G, Du M et al (2020) Muc1 Is associated with Tff2 methylation in gastric cancer. Clin Epigenet 12(1):37. https:\/\/doi.org\/10.1186\/s13148-020-00832-6","journal-title":"Clin Epigenet"},{"key":"1931_CR29","doi-asserted-by":"publisher","first-page":"954992","DOI":"10.3389\/fimmu.2022.954992","volume":"13","author":"MT Bilotta","year":"2022","unstructured":"Bilotta MT, Antignani A, Fitzgerald DJ (2022) Managing the Tme to improve the efficacy of cancer therapy. Front Immunol 13:954992. https:\/\/doi.org\/10.3389\/fimmu.2022.954992","journal-title":"Front Immunol"},{"issue":"4","key":"1931_CR30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.Cd-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA (2021) Therapeutic targeting of the tumor microenvironment. Cancer Discov 11(4):933\u2013959. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-1808","journal-title":"Cancer Discov"},{"issue":"2","key":"1931_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY et al (2019) Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet 51(2):202\u2013206. https:\/\/doi.org\/10.1038\/s41588-018-0312-8","journal-title":"Nat Genet"},{"issue":"1","key":"1931_CR32","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.esmoop.2021.100336","volume":"7","author":"M Palmeri","year":"2022","unstructured":"Palmeri M, Mehnert J, Silk AW, Jabbour SK, Ganesan S, Popli P et al (2022) Real-world application of tumor mutational burden-high (Tmb-high) and microsatellite instability (Msi) confirms their utility as immunotherapy biomarkers. ESMO Open 7(1):100336. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100336","journal-title":"ESMO Open"},{"key":"1931_CR33","doi-asserted-by":"publisher","first-page":"100645","DOI":"10.1016\/j.drup.2019.100645","volume":"46","author":"YG Assaraf","year":"2019","unstructured":"Assaraf YG, Brozovic A, Gon\u00e7alves AC, Jurkovicova D, Lin\u0113 A, Machuqueiro M et al (2019) The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist Updates 46:100645. https:\/\/doi.org\/10.1016\/j.drup.2019.100645","journal-title":"Drug Resist Updates"},{"key":"1931_CR34","doi-asserted-by":"publisher","first-page":"847345","DOI":"10.3389\/fimmu.2022.847345","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Hong M, Li Y, Chen D, Wu Y, Hu Y (2022) Programmed cell death tunes tumor immunity. Front Immunol 13:847345. https:\/\/doi.org\/10.3389\/fimmu.2022.847345","journal-title":"Front Immunol"},{"issue":"11","key":"1931_CR35","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.7150\/thno.58390","volume":"11","author":"YT Liu","year":"2021","unstructured":"Liu YT, Sun ZJ (2021) Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics 11(11):5365\u20135386. https:\/\/doi.org\/10.7150\/thno.58390","journal-title":"Theranostics"},{"key":"1931_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006773","author":"GT Clifton","year":"2023","unstructured":"Clifton GT, Rothenberg M, Ascierto PA, Begley G, Cecchini M, Eder JP et al (2023) Developing a definition of immune exclusion in cancer: results of a modified delphi workshop. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-006773","journal-title":"J Immunother Cancer"},{"issue":"11","key":"1931_CR37","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1158\/0008-5472.Can-20-3779","volume":"81","author":"F Chen","year":"2021","unstructured":"Chen F, Chen Z, Guan T, Zhou Y, Ge L, Zhang H et al (2021) N(6) -methyladenosine regulates Mrna stability and translation efficiency of Krt7 to promote breast cancer lung metastasis. Cancer Res 81(11):2847\u20132860. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-3779","journal-title":"Cancer Res"},{"issue":"1","key":"1931_CR38","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1186\/s12885-022-09983-6","volume":"22","author":"J Song","year":"2022","unstructured":"Song J, Ruze R, Chen Y, Xu R, Yin X, Wang C et al (2022) Construction of a novel model based on cell-in-cell-related genes and validation of Krt7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer. BMC Cancer 22(1):894. https:\/\/doi.org\/10.1186\/s12885-022-09983-6","journal-title":"BMC Cancer"},{"key":"1931_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105325","author":"L Communal","year":"2021","unstructured":"Communal L, Roy N, Cahuzac M, Rahimi K, K\u00f6bel M, Provencher DM et al (2021) A keratin 7 and E-cadherin signature is highly predictive of tubo-ovarian high-grade serous carcinoma prognosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22105325","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1931_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3892\/or.2020.7886","volume":"45","author":"Q An","year":"2021","unstructured":"An Q, Liu T, Wang MY, Yang YJ, Zhang ZD, Liu ZJ et al (2021) Krt7 promotes epithelial-mesenchymal transition in ovarian cancer Via the Tgf-\u0392\/Smad2\/3 signaling pathway. Oncol Rep 45(2):481\u2013492. https:\/\/doi.org\/10.3892\/or.2020.7886","journal-title":"Oncol Rep"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-023-01931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-023-01931-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-023-01931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T12:10:39Z","timestamp":1714219839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-023-01931-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":40,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1931"],"URL":"https:\/\/doi.org\/10.1007\/s10495-023-01931-4","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"19 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Nanchang University, and all patients signed informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}